bullish
I-Mab (天境生物) IPO Trading: Tiny Float and Undemanding Valuation
425 Views17 Jan 2020 11:27
I-Mab (IMAB US) raised USD 104 million at USD 14.0 per ADS, above the mid-point of the IPO price range. I-Mab will start trading today. We have...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
- I-Mab (IMAB US) - Insights On Core Products TJC4, TJ202 and TJ10129 Mar 2021
- I-Mab Placement - Heading in the Right Direction08 Feb 2021
- I-Mab (天境生物) Lock-Up Expiry: A Differentiated Immunotherapy Player Worth Reverse Inquiry08 Jul 2020
- I-Mab (天境生物) IPO Trading: Tiny Float and Undemanding Valuation17 Jan 2020
- I-Mab (天境生物) IPO: Everest Deal a Valuation Booster06 Jan 2020
- I-Mab (天境生物) Pre-IPO: Strong Management and Investor Backing with Differentiated Products04 Nov 2019
x